
Mergers in Pharma and Biotech: Shaping the Future of Clinical Trials Technology
The wave of mergers and acquisitions in the pharmaceutical and biotech sectors is reshaping the clinical trials landscape, driving substantial investments in advanced management technologies. These investments are crucial in addressing the complexities of modern clinical trials, enhancing efficiency, ensuring regulatory compliance, and ultimately accelerating the development of life-saving therapies.